Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

Before undergoing bariatric surgery like RNY, patients are required to follow a pre-op diet to reduce liver size and fat around the stomach. This makes the surgery safer and easier for the surgeon to perform. The pre-op diet typically consists of high-protein, low-carbohydrate shakes, and liquids for 1-2 weeks before surgery. It’s an important step in preparing the body for surgery and ensuring optimal recovery post-op.

Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

The Roux-en-Y gastric bypass is a common bariatric surgery where the stomach is divided into a small upper pouch and a larger lower portion. The small intestine is then rearranged to connect with the new stomach pouch. This procedure reduces food intake and limits calorie absorption, making it highly effective for weight loss.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

Slimming tablets, also known as weight-loss pills, come in various forms, including prescription medications like Orlistat and Phentermine, and over-the-counter supplements. While these pills may aid in weight loss, they should be used with caution, as they can have side effects and should be paired with healthy diet and exercise.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

The cost of lap band surgery varies by location and clinic, but it typically ranges between £1,450 and £8,000 in the UK. The procedure is less invasive and has a quicker recovery time than other bariatric surgeries, though it may require periodic adjustments.

Abdominal cancer refers to any malignant tumor in the abdomen, including stomach, liver, pancreatic, or colon cancer. Symptoms vary but may include unexplained weight loss, abdominal pain, and changes in bowel habits. Early detection is crucial for successful treatment, which may involve surgery, chemotherapy, or radiation.

The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

Sleeve surgery is another term for the gastric sleeve procedure, where most of the stomach is removed to help patients achieve significant weight loss. The procedure is less invasive than other forms of bariatric surgery, like the Roux-en-Y bypass, but still offers dramatic weight-loss results.

Ozempic is a prescription medication used primarily to treat type 2 diabetes but has recently gained attention for its off-label use in promoting weight loss. Ozempic contains semaglutide, which helps regulate blood sugar and appetite, making it an effective treatment for individuals struggling with obesity. Weight loss clinics in Turkey may prescribe Ozempic as part of a broader weight management program.

Gastric sleeve results are typically impressive, with patients losing 50-60% of their excess body weight within the first year. The surgery also leads to improvements in obesity-related conditions like diabetes, hypertension, and sleep apnea. Long-term success depends on the patient’s ability to maintain a healthy lifestyle post-surgery.

Common VSG side effects include nausea, vomiting, acid reflux, and constipation due to the smaller stomach size. Nutrient deficiencies, like vitamin B12 and iron, may occur if patients don't follow their prescribed supplements. Long-term complications can include weight regain or the development of gastroesophageal reflux disease (GERD).

The long-term effects of sleeve gastrectomy include sustained weight loss, improvement or resolution of obesity-related conditions such as type 2 diabetes, hypertension, and sleep apnea. However, patients may also experience long-term nutritional deficiencies, requiring them to take supplements like vitamin B12, calcium, and iron. Regular follow-up with healthcare providers is essential to monitor these effects.